Dolomite and Lab on a Chip Launch Productizing Science® Competition 2015
News Oct 08, 2014
Dolomite and Lab on a Chip are challenging entrepreneurial researchers, scientists and engineers to enter the Productizing Science Competition 2015, proposing novel, microfluidics-based concepts with commercial potential.
The Productizing Science Competition, jointly organized by Dolomite and Lab on a Chip, opens on the 1st of October 2014, aiming to bridge the gap between scientific innovation and commercial success by turning early stage technologies into market-leading products. This exciting competition offers the opportunity to take advantage of Dolomite’s invaluable commercial expertise and in-depth understanding of the international microfluidics market to develop idea into a profitable product.
The winning entry will benefit from Dolomite’s outstanding R&D capabilities to help take the concept or prototype through to a market-ready product, backed by Lab on a Chip’s ability to reach out to the wide-ranging scientific community to maximize marketing opportunities.
So, if users have made a scientific breakthrough or have a prototype system that they are struggling to develop - whether financially, technically or commercially - simply submit an abstract before the 30th of April 2015 for their chance to win. Enter now, and help shape the future of microfluidics!
3-D-printed Biomaterials That Degrade On Demand DevelopedNews
The temporary structures, which can be degraded away with a biocompatible chemical trigger, could be useful in fabricating microfluidic devices, creating biomaterials that respond dynamically to stimuli and in patterning artificial tissue.READ MORE
Novel Multi-Organ-on-a-Chip Could Change Approaches to Drug DevelopmentNews
Researchers have successfully connected human tissues from the lung and liver in a novel multi-organ-on-a-chip (MOC) in vitro model for toxicity testing.READ MORE
A Blood Test Can Predict Early Lung Cancer PrognosisNews
Cancer cells obtained from a blood test may be able to predict how early-stage lung cancer patients will fare.READ MORE